Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Oxid Med Cell Longev ; 2019: 4286213, 2019.
Article in English | MEDLINE | ID: mdl-31885790

ABSTRACT

Stem cells derived from elderly donors or harvested by repeated subculture exhibit a marked decrease in proliferative capacity and multipotency, which not only compromises their therapeutic potential but also raises safety concerns for regenerative medicine. NANOG-a well-known core transcription factor-plays an important role in maintaining the self-renewal and pluripotency of stem cells. Unfortunately, the mechanism that NANOG delays mesenchymal stem cell (MSC) senescence is not well-known until now. In our study, we showed that both ectopic NANOG expression and PBX1 overexpression (i) significantly upregulated phosphorylated AKT (p-AKT) and PARP1; (ii) promoted cell proliferation, cell cycle progression, and osteogenesis; (iii) reduced the number of senescence-associated-ß-galactosidase- (SA-ß-gal-) positive cells; and (iv) downregulated the expression of p16, p53, and p21. Western blotting and dual-luciferase activity assays showed that ectopic NANOG expression significantly upregulated PBX1 expression and increased PBX1 promoter activity. In contrast, PBX1 knockdown by RNA interference in hair follicle- (HF-) derived MSCs that were ectopically expressing NANOG resulted in the significant downregulation of p-AKT and the upregulation of p16 and p21. Moreover, blocking AKT with the PI3K/AKT inhibitor LY294002 or knocking down AKT via RNA interference significantly decreased PBX1 expression, while increasing p16 and p21 expression and the number of SA-ß-gal-positive cells. In conclusion, our findings show that NANOG delays HF-MSC senescence by upregulating PBX1 and activating AKT signaling and that a feedback loop likely exists between PBX1 and AKT signaling.


Subject(s)
Hair Follicle/metabolism , Mesenchymal Stem Cells/metabolism , Nanog Homeobox Protein/metabolism , Pre-B-Cell Leukemia Transcription Factor 1/metabolism , Proto-Oncogene Proteins c-akt/metabolism , Apoptosis/physiology , Cell Cycle/physiology , Cell Proliferation/physiology , Cells, Cultured , Cellular Senescence/physiology , Chromones/pharmacology , Cyclin-Dependent Kinase Inhibitor p16/biosynthesis , Cyclin-Dependent Kinase Inhibitor p21/biosynthesis , Enzyme Activation , HEK293 Cells , Hair Follicle/cytology , Humans , Mesenchymal Stem Cells/cytology , Morpholines/pharmacology , Nanog Homeobox Protein/biosynthesis , Nanog Homeobox Protein/genetics , Poly (ADP-Ribose) Polymerase-1/metabolism , Pre-B-Cell Leukemia Transcription Factor 1/biosynthesis , Pre-B-Cell Leukemia Transcription Factor 1/genetics , Promoter Regions, Genetic , Protein Kinase Inhibitors/pharmacology , Proto-Oncogene Proteins c-akt/antagonists & inhibitors , Signal Transduction/drug effects , Tumor Suppressor Protein p53/biosynthesis , Up-Regulation
2.
Neurotoxicol Teratol ; 59: 1-15, 2017.
Article in English | MEDLINE | ID: mdl-27751817

ABSTRACT

Exposure to arsenic, a common environmental toxin found in drinking water, leads to a host of neurological pathologies. We have previously demonstrated that developmental exposure to a low level of arsenic (50ppb) alters epigenetic processes that underlie deficits in adult hippocampal neurogenesis leading to aberrant behavior. It is unclear if arsenic impacts the programming and regulation of embryonic neurogenesis during development when exposure occurs. The master negative regulator of neural-lineage, REST/NRSF, controls the precise timing of fate specification and differentiation of neural stem cells (NSCs). Early in development (embryonic day 14), we observed increased expression of Rest, its co-repressor, CoREST, and the inhibitory RNA binding/splicing protein, Ptbp1, and altered expression of mRNA spliced isoforms of Pbx1 that are directly regulated by these factors in the male brain in response to prenatal 50ppb arsenic exposure. These increases were concurrent with decreased expression of microRNA-9 (miR-9), miR-9*, and miR-124, all of which are REST/NRSF targets and inversely regulate Rest expression to allow for maturation of NSCs. Exposure to arsenic decreased the formation of neuroblasts in vitro from NSCs derived from male pup brains. The female response to arsenic was limited to increased expression of CoREST and Ptbp2, an RNA binding protein that allows for appropriate splicing of genes involved in the progression of neurogenesis. These changes were accompanied by increased neuroblast formation in vitro from NSCs derived from female pups. Unexposed male mice express transcriptomic factors to induce differentiation earlier in development compared to unexposed females. Thus, arsenic exposure likely delays differentiation of NSCs in males while potentially inducing precocious differentiation in females early in development. These effects are mitigated by embryonic day 18 of development. Arsenic-induced dysregulation of the regulatory loop formed by REST/NRSF, its target microRNAs, miR-9 and miR-124, and RNA splicing proteins, PTBP1 and 2, leads to aberrant programming of NSC function that is perhaps perpetuated into adulthood inducing deficits in differentiation we have previously observed.


Subject(s)
Arsenic/toxicity , Heterogeneous-Nuclear Ribonucleoproteins/biosynthesis , Nerve Tissue Proteins/biosynthesis , Neural Stem Cells/drug effects , Polypyrimidine Tract-Binding Protein/biosynthesis , Prenatal Exposure Delayed Effects/metabolism , Repressor Proteins/biosynthesis , Sex Characteristics , Animals , Cells, Cultured , Co-Repressor Proteins , Female , Male , Mice , MicroRNAs/biosynthesis , Neurogenesis/drug effects , Pre-B-Cell Leukemia Transcription Factor 1/biosynthesis , Pregnancy
SELECTION OF CITATIONS
SEARCH DETAIL
...